J&J Unit Levied $400M, Admits Off-Label Risperdal Marketing

A Pennsylvania federal judge on Thursday approved a $400 million criminal penalty against Johnson & Johnson unit Janssen Pharmaceuticals Inc. after the company formally admitted to improperly encouraging doctors to use Risperdal to treat dementia ...read more

  • Tags: